COVID-19 Workshop on August 20: Pain Management in COVID-19

Thursday, August 20, 10:30-11AM EDT

Our COVID-19 Workshop Series continues on Thursdays, 10:30–11AM.

Join us as we discuss pain management during the COVID-19 pandemic. We’ll cover obstacles and and share insights.


Have specific questions?

Let us know and we’ll address them in our upcoming webinars. Email us at:

Our Speakers

Dr. Jeffrey Fudin

Diplomate, Academy of Integrative Pain Management

Dr. Fudin graduated from Albany College of Pharmacy & Health Sciences with his Bachelors Degree and Pharm.D. He completed an Oncology/Hematology fellowship at SUNY/Upstate Medical Center. He is a Diplomate to the Academy of Integrative Pain Management and a Fellow to the American College of Clinical Pharmacy, the American Society of Health-system Pharmacists, and the Federation of State Medical Board.

Dr. Fudin is a Section Editor for Pain Medicine, Co-Editor-At-Large for Practical Pain Management, Founder/Chairman of Professionals for Rational Opioid Monitoring & Pharmacotherapy, and peer reviewer for several professional journals. He has participated in developing practice guidelines for use of opioids in chronic noncancer pain (APS, AAPM collaborative) and participated in national (US Health and Human Services) and international guideline development for various pain types including but not limited to arthritis, fibromyalgia, and palliative care. He has also participated in the development and co-authored consensus guidelines for the treatment of opioid-induced constipation and for urine drug monitoring.

He practices as a Clinical Pharmacy Specialist and Director, PGY-2 Pharmacy Pain Residency Programs at the Stratton Veterans Administration Medical Center in Albany NY. He holds adjunct faculty positions at Western New England University College of Pharmacy in Springfield MA and Albany College of Pharmacy & Health Sciences. Dr. Fudin has been an invited speaker on pain management nationally and internationally.

Dr. Fudin is a Founder and Board of Trustee for the Society of Palliative Care Pharmacists where he serves on several committees. He is a member of several professional organizations and is appointed as a Board Member to the New York State Office of Professional Medical Conduct.

He is owner and managing editor for and Founder and CEO of Remitigate LLC, a software development company that has launched an application to help clinicians interpret urine drugs screens (Urintel) and another that interprets risk of opioid-induced respiratory depression and guides clinicians in qualifying patients for in-home naloxone. There are several pipeline products including a pharmacogenetic and opioid taper applications plus other opioid safety software initiatives in development.

He is also the Founder of Pharmacist Consulting Services (DBA Remitigate Therapeutics), a virtual patient consultation service that uses technology platforms to guide clinicians towards viable medication options and recommended approaches when complex pharmacotherapeutic issues and dilemmas arise which might otherwise  limit successful patient outcomes.

Dr. Fudin is a prolific lecturer, writer, editor, and teacher, and researcher, with over 350 publications on pain management topics.

Darren M. Triller, PharmD

Medication Safety Pharmacist, IPRO

Dr. Triller is a clinical pharmacist with 30 years of experience in medication safety and quality improvement. He has led multiple state and national efforts relating to high-risk drugs and serves as IPRO’s lead for the drug safety aim for the current QIN-QIO contract.